**U.S.
      SECURITIES AND EXCHANGE COMMISSION**


**Washington,
      D.C. 20549**





**FORM
      10-QSB**





x QUARTERLY
      REPORT
      PURSUANT SECTION 13 OR 15(d) OF THE


SECURITIES
      EXCHANGE ACT OF 1934





For
      the
      quarterly period ended September 30, 2007





o TRANSITION
      REPORT
      PURSUANT SECTION 13 OR 15(d) OF THE


SECURITIES
      EXCHANGE ACT OF 1934





For
      the
      transition period from __________ to __________





Commission
      file number 000-52643




**SFH
      I ACQUISITION CORP.**


(Exact
      name of small business issuer as specified in its charter)





Delaware
            
            20-5941535(State
                or other jurisdiction of
            
            (I.R.S.
                employerincorporation
                or organization)
            
            identification
                number)




17395
                North Bay Road, Suite 102Sunny
                Isles Beach, FL
            
            33160(Address
                of principal executive offices)
            
            (Zip
                Code)




Issuer's
      telephone number, including area code: (786) 629-0334





No
      Change


(Former
      name, former address and former


fiscal
      year, if changed since last report)




Check
      whether the issuer (1) filed all reports required to be filed by Section 13
      or
      15(d) of the Exchange Act during the past 12 months (or for such shorter period
      that the registrant was required to file such reports), and (2) has been subject
      to such filing requirements for the past 90 days. Yes x No o





Check
      whether the issuer is a shell company (as defined in Rule 12b-2 of the Exchange
      Act). Yes x No o .





APPLICABLE
      ONLY TO CORPORATE ISSUERS





State
      the
      number of shares outstanding of each of the issuer's classes of common equity,
      as of the latest practicable date: 5,000,000 shares of Common Stock, par value
      $.0001 per share, outstanding as of September 30, 2007.





Transitional
      Small Business Disclosure Format (Check one):   YES o NO x









**SFH
      I ACQUISITION CORP.**





**-
      INDEX -**




PagePART
              I - FINANCIAL INFORMATION:Item
                1. Financial Statements:
            1Balance
                Sheet – September 30, 2007 (unaudited)
            F-1Statement
                of Operations (unaudited) for the three months ending September 30,
                2007,
                for the nine-month
              period
                ending September 30, 2007, and for the cumulative period from November
                20,
                2006 (inception) to September 30, 2007
            F-2Statement
                of Cash Flows (unaudited) for the nine-month period ending September
                30,
                2007, and for the
              cumulative
                period from November 20, 2006 (inception) to September 30,
                2007
            F-3Notes
                to Unaudited Financial Statements
            F-4Item
                2. Management's Discussion and Analysis or Plan of
                Operation
            2Item
                3. Controls and Procedures
            5PART
                II - OTHER INFORMATION:Item
                1. Legal Proceedings
            6Item
                2. Unregistered Sales of Equity Securities and Use of
                Proceeds
            6Item
                3. Defaults Upon Senior Securities
            6Item
                4. Submission of Matters to a Vote of Security Holders
            6Item
                5. Other Information
            6Item
                6. Exhibits
            6Signatures
            7










**PART
      I - FINANCIAL INFORMATION**





**Item
      1. Financial Statements.**





The
      accompanying financial statements have been prepared in accordance with
      generally accepted accounting principles for interim financial information
      and
      in accordance with the instructions for Form 10-QSB. Accordingly, they do not
      include all of the information and footnotes required by generally accepted
      accounting principles for complete financial statements.





In
      the
      opinion of management, the financial statements contain all material
      adjustments, consisting only of normal recurring adjustments necessary to
      present fairly the financial condition, results of operations, and cash flows
      of
      the Company for the interim periods presented.





The
      results for the period ended September 30, 2007 are not necessarily indicative
      of the results of operations for the full year.




1





**SFH
      I Acquisition Corp.**


**(A
      Development Stage Company)**


**BALANCE
      SHEET**


**September
      30, 2007**


**(Unaudited)**




ASSETSCurrent
                assets:Cash
                and cash equivalents
            
            $
            7,222Total
                assets
            
            $
            7,222LIABILITIES
                AND STOCKHOLDERS' DEFICITCurrent
                liabilities:Accounts
                payable and accrued expenses
            
            $
            9,099Notes
                payable to a stockholder, including accrued interest of
                $1,256
            
            
            41,256Total
                current liabilities
            
            
            50,355Stockholders'
                deficitPreferred
                stock; $.0001 par value, 20,000,000 shares authorized, none issued
                and
                outstanding
            
            
            -Common
                stock; $.0001 par value, 100,000,000 shares authorized, 5,000,000
                shares issued and outstanding
            
            
            500Accumulated
                deficit
            
            
            (43,633
            )Total
                stockholders' deficit
            
            
            (43,133
            )Total
                liabilities and stockholders' deficit
            
            $
            7,222





See
      accompanying notes to unaudited financial statements





F-1




**SFH
      I Acquisition Corp.**


**(A
      Development Stage Company)**


**STATEMENTS
      OF OPERATIONS**




Three-month period
            
            Nine-month period
            
            From November 20, 2006ending September 30,
            
            ending September 30,
            
            (Inception) to September 30,2007
            
            2007
            
            2007(Unaudited)
            
            (Unaudited)
            
            (Unaudited)Operating
                expenses:Selling,
                general, and administrative expenses
            
            $
            2,450
            
            $
            9,347
            
            $
            42,376Other
                expense:Interest
                expense-related party
            
            
            398
            
            
            1,151
            
            
            1,257Net
                loss
            
            $
            (2,848
            )
            $
            (10,498
            )
            $
            (43,633
            )Basic
                and diluted earnings per common share
            
            $
            (0.00
            )
            $
            (0.00
            )
            $
            (0.01
            )Basic
                and diluted weighted average common shares outstanding
            
            
            5,000,000
            
            
            5,000,000
            
            
            5,000,000





See
      accompanying notes to unaudited financial statements


F-2




**SFH
      I Acquisition Corp.**


**(A
      Development Stage Company)**


**STATEMENTS
      OF CASH FLOWS**


Nine-month period
            
            From November 20, 2006ending September 30,
            
            (Inception) to September 30,2007
            
            2007(Unaudited)
            
            (Unaudited)Cash
                flows from operating activities:Net
                loss
            
            $
            (10,498
            )
            $
            (43,633
            )Adjustments
                to reconcile net loss to net cash used in operating
                activities:Changes
                in operating assets and liabilities:Accrued
                interest on notes payable to a stockholder
            
            
            1,150
            
            
            1,256Accounts
                payable and accrued expenses
            
            
            (4,771
            )
            
            9,099Net
                cash used in operating activities
            
            
            (14,119
            )
            
            (33,278
            )Cash
                flows from financing activities:Proceeds
                from issuance of shares of common stock
            
            
            -
            
            
            500Proceeds
                from issuance of notes payable to a stockholder
            
            
            20,000
            
            
            40,000Net
                cash provided by financing activities
            
            
            20,000
            
            
            40,500Net
                increase in cash
            
            
            5,881
            
            
            7,222Cash,
                beginning of period
            
            
            1,341
            
            
            -Cash,
                end of period
            
            $
            7,222
            
            $
            7,222




See
      accompanying notes to unaudited financial statements




F-3


**SFH
      I ACQUISITION CORP.**


**(A
      Development Stage Company)**


**NOTES
      TO UNAUDITED FINANCIAL STATEMENTS**


**September
      30, 2007**




**Note
      1 -Organization and Description of Business, Basis of Presentation and Going
      Concern**





**Organization
      and Description of Business**





SFH
      II
      Acquisition Corp. (the “Company”), a development stage company as defined in
      Financial Accounting Standards Board Statement No. 7, was formed in Delaware
      on
      November 20, 2006. The Company’s fiscal year end is December 31.





The
      Company’s primary purpose is to acquire an operating business. The Company has
      not identified an acquisition target yet. In this regard, the Company is a
      “blank check” company, which the SEC defines as “a development stage company”
that has no specific business plan or purpose, or which has indicated that
      its
      business plan is to engage in a merger or acquisition with an unidentified
      company or companies, or other entity or person; and has issued ‘penny stock,’
as defined in Rule 3a 51-1 under the Securities and Exchange Act of 1934. Many
      states have enacted statutes, rules and regulations limiting the sale of
      securities of “blank check” companies in their respective jurisdictions.
      Management does not intend to undertake any efforts to cause a market to develop
      in its securities, either debt or equity, until such time as the Company
      concludes a business combination, to the extent that occurs.





The
      Company was organized as a vehicle to investigate and, if such investigation
      warrants, acquire a target company or business seeking the perceived advantages
      of being a publicly held corporation and, to a lesser extent, that desires
      to
      employ the Company’s funds in its business. The Company’s principal business
      objective for the next 12 months and beyond such time will be to achieve
      long-term growth potential through a combination with a business rather than
      immediate, short-term earnings. The Company will not restrict its potential
      candidate target companies to any specific business, industry or geographical
      location and, thus, may acquire any type of business. The analysis of new
      business opportunities will be undertaken by or under the supervision of the
      officers and directors of the Company.





**Basis
      of Presentation and Going Concern**




The
      Company’s financial statements have been presented on the basis that it is a
      going concern, which contemplates the realization of assets and the satisfaction
      of liabilities in the normal course of business. The Company is in the
      development stage and has not earned any revenues from operations to date.
      These
      conditions raise substantial doubt about its ability to continue as a going
      concern.





**Note
      2 - Summary of Significant Accounting Policies**





We
      have
      not generated revenue since our inception on November 20, 2006 and incurred
      net
      losses of $10,498 for nine-month period ending September 30, 2007. As a result,
      our current operations are not an adequate source of cash to fund future
      operations. Our ability to continue as a going concern is dependent upon our
      ability to obtain the necessary financing to meet our obligations and repay
      our
      liabilities when they become due and to generate profitable operations in the
      future. We plan to continue to provide for our capital requirements through
      the
      sale of equity securities and debt, however, we have no firm commitments from
      any third party to provide this financing and we cannot assure you we will
      be
      successful in raising working capital as needed. There are no assurances that
      we
      will have sufficient funds to execute our business plan, pay our obligations
      as
      they become due or generate positive operating results.




F-4




**SFH
      I ACQUISITION CORP.**


**(A
      Development Stage Company)**


**NOTES
      TO UNAUDITED FINANCIAL STATEMENTS**


**September
      30, 2007**





**Note
      2 - Summary of Significant Accounting Policies - Continued**




**Cash
      and Cash Equivalents**





Cash
      and
      cash equivalents consist primarily of cash in banks. The Company considers
      cash
      equivalents to include all highly liquid investments with original maturities
      of
      three months or less to be cash equivalents.




**Development
      Stage**





The
      Company’s primary purpose for the time being is to acquire an operating
      business. The Company spends most of its time in assessing acquisition
      targets.




**Fair
      Value of Financial Instruments**





The
      carrying value of cash and cash equivalents, accounts payable and accrued
      expenses, note payable to a stockholder, and advances from a related party
      approximate their fair value due to their short-term maturities.




**Income
      Taxes**





Income
      taxes are accounted for in accordance with SFAS No. 109, Accounting for Income
      Taxes. SFAS No. 109 requires the recognition of deferred tax assets and
      liabilities to reflect the future tax consequences of events that have been
      recognized in the Company’s financial statements or tax returns. Measurement of
      the deferred items is based on enacted tax laws. In the event the future
      consequences of differences between financial reporting bases and tax bases
      of
      the Company’s assets and liabilities result in a deferred tax asset, SFAS No.
      109 requires an evaluation of the probability of being able to realize the
      future benefits indicated by such assets. A valuation allowance related to
      a
      deferred tax asset is recorded when it is more likely than not that some or
      the
      entire deferred tax asset will not be realized.





For
      federal income tax purposes, substantially all expenses must be deferred until
      the Company commences business and then they may be written off over a 60-month
      period. These expenses will not be deducted for tax purposes and will represent
      a deferred tax asset. The Company will provide a valuation allowance in the
      full
      amount of the deferred tax asset since there is no assurance of future taxable
      income. Tax deductible losses can be carried forward under current applicable
      law for 20 years until utilized.




**Use
      of Estimates**




The
      preparation of financial statements in accordance with accounting principles
      generally accepted in the United
      States requires management to make estimates and assumptions that affect the
      reported amounts of assets and liabilities and disclosure of contingent assets
      and liabilities at the date of the financial statements and the reported amounts
      of revenues and expenses during the reporting
      periods. Significant estimates made by management include, but are not limited
      to, the realization of receivables. Actual results may differ from these
      estimates and assumptions.




F-5




**SFH
      I ACQUISITION CORP.**


**(A
      Development Stage Company)**


**NOTES
      TO UNAUDITED FINANCIAL STATEMENTS**


**September
      30, 2007**





**Note
      2 - Summary of Significant Accounting Policies- Continued**





**Basic
      and Diluted Earnings per Common Share**





Basic
      earnings per common share are calculated by dividing income available to
      stockholders by the weighted-average number of common shares outstanding during
      each period. Diluted earnings per share are computed using the weighted average
      number of common shares outstanding plus the dilutive effects of outstanding
      options and warrants to acquire common shares during the period. In loss
      periods, dilutive common equivalent shares are excluded because the effect
      would
      be anti-dilutive. The Company had not issued any dilutive common share
      equivalents at September 30, 2007.





**Recently
      Issued Accounting Pronouncements**





On
      July
      13, 2006, the Financial Accounting Standards Board (FASB) issued FASB
      Interpretation No. 48, (“FIN 48”), entitled, “Accounting for Uncertainty in
      Income Taxes - an Interpretation of FASB Statement No. 109”. Concurrently,
      FASB issued a FASB staff position (FSP) relating to income taxes, (FSP)
      No.  FAS 13-2, “Accounting for a Change or Projected Change in the Timing
      of Cash Flows Relating to Income Taxes Generated by a Leveraged Lease
      Transaction.” FASB’s
      summary of FIN
      48 notes that differences between tax positions recognized in the financial
      statements and tax positions taken in the tax return (referred to commonly
      as
“book” vs. “tax”) will generally result in: (a) an increase in a liability
      for income taxes payable or a reduction of an income tax refund receivable,
      (b) a reduction in a deferred tax asset or an increase in a deferred tax
      liability, or (c) both of the above.  FIN 48 requires the affirmative
      evaluation that it is more likely than not, based on the technical merits of
      a
      tax position, that an enterprise is entitled to economic benefits resulting
      from
      positions taken in income tax returns. Further, if a tax position does not
      meet
      the more-likely-than-not recognition threshold, the benefit of that position
      is
      not recognized in the financial statements. Additionally, FIN 48 establishes
      guidance for “derecognition” of previously recognized deferred tax items, and
      sets forth disclosure requirements. The effective date of FIN 48 is for fiscal
      years beginning after December 15, 2006.





The
      Company does not believe that, for the foreseeable future, FIN 48, once adopted,
      will have a significant impact on its financial position, operating results,
      or
      cash flows.





In
      September 2006, the FASB issued FASB Statement No. 157. This Statement defines
      fair value, establishes a framework for measuring fair value in generally
      accepted accounting principles (GAAP), and expands disclosures about fair value
      measurements. This Statement applies under other accounting pronouncements
      that
      require or permit fair value measurements, the Board having previously concluded
      in those accounting pronouncements that fair value is a relevant measurement
      attribute. Accordingly, this Statement does not require any new fair value
      measurements. However, for some entities, the application of this Statement
      will
      change current practices. This Statement is effective for financial statements
      for fiscal years beginning after November 15, 2007. Earlier application is
      permitted provided that the reporting entity has not yet issued financial
      statements for that fiscal year. Management believes that, for the foreseeable
      future, this Statement will have no impact on the financial statements of the
      Company once adopted.




F-6




**SFH
      I ACQUISITION CORP.**


**(A
      Development Stage Company)**


**NOTES
      TO UNAUDITED FINANCIAL STATEMENTS**


**September
      30, 2007**





**Note
      2 - Summary of Significant Accounting Policies- Continued**




In
      February 2007, the FASB issued FASB Statement No. 159 “ *The
      Fair Value Option for Financial Assets and Financial Liabilities—Including an
      amendment of FASB Statement No. 115* ”.
      This
      Statement permits entities to choose to measure many financial instruments
      and
      certain other items at fair value. The objective is to improve financial
      reporting by providing entities with the opportunity to mitigate volatility
      in
      reported earnings caused by measuring related assets and liabilities differently
      without having to apply complex hedge accounting provisions. This Statement
      is
      expected to expand the use of fair value measurement, which is consistent with
      the FASB’s long-term measurement objectives for accounting for financial
      instruments. This Statement applies to all entities, including not-for-profit
      organizations. Most of the provisions of this Statement apply only to entities
      that elect the fair value option.





However,
      the amendment to FASB Statement No. 115, “ *Accounting
      for Certain Investments in Debt and Equity Securities* ,”
      applies to all entities with available-for-sale and trading securities. Some
      requirements apply differently to entities that do not report net income. The
      following are eligible items for the measurement option established by this
      Statement:





1.
            Recognized
                financial assets and financial liabilities
                except:





a)
            An
              investment in a subsidiary that the entity is required to
              consolidate; b)
            An
                interest in a variable interest entity that the entity is required
                to
                consolidate;


c)
            Employers’
                and plans’ obligations (or assets representing net overfunded positions)
                for pension benefits, other postretirement benefits (including health
                care
                and life insurance benefits), postemployment benefits, employee stock
                option and stock purchase plans, and other forms of deferred compensation
                arrangements,
                as defined in FASB Statements No. 35,*“Accounting
                and Reporting by Defined Benefit Pension Plans”*,
                No. 87,*“Employers’
                Accounting for Pensions”*,
                No. 106,*“Employers’
                Accounting for Postretirement Benefits Other Than
                Pensions”*,
                No. 112,*“Employers’
                Accounting for Postemployment**Benefits”*,
                No. 123 (revised December 2004),*“Share-Based
                Payment”, No. 43, “Accounting for Compensated Absences”*,
                No. 146,*“Accounting
                for Costs Associated with Exit or Disposal Activities”*,
                and No. 158,*“Employers’**Accounting
                for Defined Benefit Pension and Other Postretirement
                Plans”*,
                and APB Opinion No. 12,*“Omnibus
                Opinion—1967”*; d)
            Financial
                assets and financial liabilities recognized under leases as defined
                in
                FASB Statement No. 13,*“Accounting
                for Leases”*(This exception does not apply to a guarantee of a third-party lease
                obligation or a contingent obligation arising from a cancelled
                lease.);





F-7




**SFH
      I ACQUISITION CORP.**


**(A
      Development Stage Company)**


**NOTES
      TO UNAUDITED FINANCIAL STATEMENTS**


**September
      30, 2007**





**Note
      2 - Summary of Significant Accounting Policies- Continued**





e)
            Deposit
                liabilities, withdrawable on demand, of banks, savings and loan
                associations, credit unions, and other similar depository
                institutions;


f)
            Financial
                instruments that are, in whole or in part, classified by the issuer
                as a
                component of shareholder’s equity (including “temporary equity”). An
                example is a convertible debt security with a noncontingent beneficial
                conversion feature.


2.
            Firm
                commitments that would otherwise not be recognized at inception and
                that
                involve only financial instruments;


3.
            Nonfinancial
                insurance contracts and warranties that the insurer can settle by
                paying a
                third party to provide those goods or services;
                and


4.
            Host
                financial instruments resulting from separation of an embedded
                nonfinancial derivative instrument from a nonfinancial hybrid
                instrument.





The
      fair
      value option established by this Statement permits all entities to choose to
      measure eligible items at fair value at specified election dates. A business
      entity shall report unrealized gains and losses on items for which the fair
      value option has been elected in earnings (or another performance indicator
      if
      the business entity does not report earnings) at each subsequent reporting
      date.
      A not-for-profit organization shall report unrealized gains and losses in its
      statement of activities or similar statement.





The
      fair
      value option:




·
            May
                be applied instrument by instrument, with a few exceptions, such
                as
                investments otherwise accounted for by the equity method·
            Is
                irrevocable (unless a new election date occurs)





·
            Is
                applied only to entire instruments and not to portions of instruments.





This
      Statement is effective as of the beginning of an entity’s first fiscal year that
      begins after November 15, 2007. Early adoption is permitted as of the beginning
      of a fiscal year that begins on or before November 15, 2007, provided the entity
      also elects to apply the provisions of FASB Statement No. 157, “ *Fair
      Value Measurements* ”.
      No
      entity is permitted to apply this Statement retrospectively to fiscal years
      preceding the effective date unless the entity chooses early adoption. The
      choice to adopt early should be made after issuance of this Statement but within
      120 days of the beginning of the fiscal year of adoption, provided the entity
      has not yet issued financial statements, including required notes to those
      financial statements, for any interim period of the fiscal year of adoption.
      This Statement permits application to eligible items existing at the effective
      date (or early adoption date).





**Note
      3 - Accounts Payable and Accrued Expenses**




Accounts
      payable and accrued expenses at September 30, 2007 consisted exclusively of
      accrued professional fees.




F-8




**SFH
      I ACQUISITION CORP.**


**(A
      Development Stage Company)**


**NOTES
      TO UNAUDITED FINANCIAL STATEMENTS**


**September
      30, 2007**







**Note
      4 - Related Party Transactions**




The
      Company neither owns nor leases any real or personal property. Most office
      services are provided without charge by our president and sole director. Such
      costs are immaterial to the financial statements and accordingly, have not
      been
      reflected therein.





Our
      officers and directors are involved in other business activities and may in
      the
      future become involved in other business pursuits when opportunities present
      themselves. As a result of these other activities, such persons may face a
      conflict in selecting between the Company and their other business interests.
      The Company has not formulated a policy for the resolution of such
      conflicts.





During
      January 2007, the Company issued a note payable of $10,000 to a major
      stockholder. The notes bear interest at 4.75% per annum. The note is payable
      on
      or before the first day upon which the Company receives proceeds from equity
      investments aggregating at least $250,000. Any overdue principal bears interest
      at 15% per annum and is payable on demand.





During
      May 2007, the Company issued a note payable of $5,000 to a major stockholder.
      The notes bear interest at 4.75% per annum. The note is payable on or before
      the
      first day upon which the Company receives proceeds from equity investments
      aggregating at least $250,000. Any overdue principal bears interest at 15%
      per
      annum and is payable on demand.





During
      September 2007, the Company issued a note payable of $5,000 to a major
      stockholder. The notes bear interest at 4.75% per annum. The note is payable
      on
      or before the first day upon which the Company receives proceeds from equity
      investments aggregating at least $250,000. Any overdue principal bears interest
      at 15% per annum and is payable on demand.




September
      Note





The
      interest expense associated with the aforementioned notes payable amounted
      to
      $1,150 during the nine-month period ended September 30, 2007.





**Note
      5 - Stockholders’ Deficit**





**Common
      Stock**





The
      Company is authorized to issue 100,000,000 shares of common stock.





**Preferred
      Stock**





The
      Company is authorized to issue 20,000,000 shares of preferred stock with such
      designations, voting and other rights and preferences as may be determined
      from
      time to time by the Board of Directors.




F-9




**Item
      2. Management's Discussion and Analysis or Plan of
      Operation.**




CAUTIONARY
      NOTE REGARDING FORWARD-LOOKING STATEMENTS





Certain
      statements in this quarterly report on Form 10-QSB contain or may contain
      forward-looking statements that are subject to known and unknown risks,
      uncertainties and other factors which may cause actual results, performance
      or
      achievements to be materially different from any future results, performance
      or
      achievements expressed or implied by such forward-looking statements. These
      forward-looking statements were based on various factors and were derived
      utilizing numerous assumptions and other factors that could cause our actual
      results to differ materially from those in the forward-looking statements.
      These
      factors include, but are not limited to, economic, political and market
      conditions and fluctuations, government and industry regulation, interest rate
      risk, U.S. and global competition, and other factors. Most of these factors
      are
      difficult to predict accurately and are generally beyond our control. You should
      consider the areas of risk described in connection with any forward-looking
      statements that may be made herein. Readers are cautioned not to place undue
      reliance on these forward-looking statements, which speak only as of the date
      of
      this report. Readers should carefully review this quarterly report in its
      entirety, including but not limited to our financial statements and the notes
      thereto. Except for our ongoing obligations to disclose material information
      under the Federal securities laws, we undertake no obligation to release
      publicly any revisions to any forward-looking statements, to report events
      or to
      report the occurrence of unanticipated events. For any forward-looking
      statements contained in any document, we claim the protection of the safe harbor
      for forward-looking statements contained in the Private Securities Litigation
      Reform Act of 1995.





**Background**





We
      were
      organized as a vehicle to investigate and, if such investigation warrants,
      acquire a target company or business seeking the perceived advantages of being
      a
      publicly-held corporation. In furtherance thereof, we have signed letters
      of  intent
      to
      acquire three companies involved in the pharmaceutical field. Two of these
      companies are located in the Russian republic and the third is a pharmacy
      located in Florida, and is operated by our president.




We
      have
      signed a Letter of Intent to acquire a 30% equity interest in Intercare
      Holdings, LLC and will have an option to acquire an additional 19%. The Letter
      of Intent contemplates that we will acquire ANKITAPHARM
      (a 100% subsidiary of INTERCARE) and 100% of Pharmco, LLC. We will issue 24
      million shares of our common stock for the acquisitions of the Russian entities
      and an additional 12 million shares of common stock for the acquisition of
      Pharmco.




There
      can
      be no assurance that we will be able to close on these acquisitions or that
      we
      will have sufficient funding to expand their operations. We may close on one
      transaction and not the other. Each transaction is subject to execution of
      a
      definitive stock exchange agreement and the completion by each party of further
      due diligence. The acquisition of the Russian entities may require approval
      from
      the government. In addition the Securities and Exchange Commission (“SEC”) will
      require each of the targeted entities to provide audited financial statements
      according to US Generally Accepted Accounting Principles (“GAAP”). Delivery of
      audited financial statements in conformity with GAAP will be a condition
      precedent to closing any acquisition.




***INTERCARE***





The
      Russian Pharmaceutical Market -
      Pharmaceuticals is one of the fastest growing industries of Russia’s economy.
      There are two fundamental reasons for such dynamics: the changing demography
      (increase in the average population aged up to 37.7 years) and a higher income
      level from USD 80 in 2000 to almost USD 400 in 2005. These factors resulted
      in a
      larger consumption of pharmaceutical products and the displacement of cheap
      medicines by more expensive high quality ones.




2




Market
      Position -
      InterCare operates approximately 36 distribution centers which include its
      corporate office. The company was established by Dr. Sanjiw K. Singh and his
      two
      brothers, Raju K. Singh and Satyendra K. Singh.





Infrastructure -
      InterCare is headquartered in Moscow, has 35 distribution centers, 28 branches
      and 7 representative offices located in main Russian cities. The company has
      presence in such Russia’s regions as, Chita region, Buryatia, and Primorsky
      region, where other Russian distributors have no outlets. Regional sales
      contribute to the major part of the turn-over of the company.





SFH I





The
      total
      area of all distribution centers is 40,630 sqm, 31,810 sqm of which is the
      area
      of warehouse. The distribution infrastructure is currently underutilized.





Business -
      Intercare works only in commercial segment of pharmaceutical distribution market
      and does not participate in the government reimbursement program (DLO). The
      company offers pharmaceutical and other healthcare products to its clients,
      a
      majority of which are pharmacies. The company works with foreign and Russian
      suppliers. Expanding this distribution network and increasing its efficiency
      will require a significant capital infusion of at least $15 million. Even
      assuming that we close on the acquisition, it is unlikely that we will be able
      to fund this expansion without third party financing. There can be no assurance
      that this financing will be available for Intercare.





**ANKITAFARM**





The
      Letter of Intent contemplates that we acquire 100% of ANKITAFARM, a 100 %
      subsidiary of INTERCARE, engaged in the manufacture of generic medical products
      some with immediate release and others with controlled time release, by
      utilizing delivery release technologies and set fixed dosages. The Company
      concentrates its efforts and applies its advanced technologies to develop
      moderately priced and affordable drugs that presently are very costly,
      unaffordable or unavailable in the Russian market at affordable
      prices.





The
      Company has limited operations to date.





**PHARMCO**





We
      intend
      to acquire a 100% interest in Pharmco. Pharmco operates a pharmaceutical outlet
      (a retail distributor supplying various pharmaceutical products) located in
      the
      Miami metropolitan area and is specialized in servicing institutional clients
      namely ALF (assisted living facility) segment. Pharmco is situated in a high
      density population area and as such provides services to a high volume of retail
      customers.




3




Pharmco
      derives most of its revenues from servicing assisted living facilities (“ALF”).
      In addition to the traditional reimbursements from insurance companies, Meidcare
      and Medicaid, Pharmco seeks to become a supplier of low cost drugs to make
      them
      more available to those facilities and to individuals with limited means.





Assuming
      we are successful in closing on these transactions, our initial focus will
      be
      Ankitafarm. Current management intends to focus on the development of generic
      versions for popular brand name drugs in the Russian Federation. This will
      require a capital infusion of up to $5 million. There can be no assurance that
      we will be successful in securing this additional financing and/or expanding
      the
      Company’s current operations. If we cannot secure additional financing, our
      primary focus will be Pharmco, an entity controlled by our current president,
      Armen Karapetyan.





**Revenues** :





The
      Company has not realized any revenues from operations since November 20, 2006
      (inception), and its plan of operation for the next twelve months shall be
      to
      continue its efforts to locate suitable acquisition candidates. The Company
      can
      provide no assurance that it can continue to satisfy its cash requirements
      for
      at least the next twelve months. It is not anticipated at present that it will
      experience any change in its current number of employees until such time as
      it
      may consummate a business combination.




*Three-Month
      and Nine-Month Periods Ended September 30, 2007*





*Operational
      Expenses*





Total
      operating expenses for the three-month period ended September 30, 2007 were
      $2,450. Total operating expenses for the nine-month period ended September
      30, 2007 were $9,347. These expenses constituted professional and related
      fees.





The
      Company incurred a net loss of $(2,848) for the three-month period ended
      September 30, 2007, $(10,498) for the nine-month period ended September 30,
      2007, and $(43,633) for the period from November 20, 2006 (inception) to
      September 30, 2007. It is management's assertion that without an additional
      infusion of capital these circumstances may hinder the Company's ability to
      continue as a going concern. (See “Subsequent Events”).





*Liquidity
      and Capital Resources*





We
      do not
      have any revenues from operations and, absent the closing of our proposed
      acquisitions with either Pharmco, Intercare or AnkitaFarm, we will not have
      any
      revenues from operations. We will be dependent upon future loans or equity
      investments to sustain our operations. (See “Subsequent Events”).





At
      September 30, 2007, the Company had cash of $7,222, its only asset, and total
      current liabilities of $50,355 which include loans from shareholders totaling
      $41,256. We have a working capital deficit of $(43,133).





*Results
      of Operations*





The
      Company has not conducted any active operations since inception, except for
      its
      efforts to locate suitable acquisition candidates. No revenue has been generated
      by the Company from November 20, 2006 (inception) to September 30, 2007. It
      is
      unlikely the Company will have any revenues unless it is able to close on any
      of
      the potential acquisition candidates, of which there can be no
      assurance.





Since
      November 20, 2006 (inception), selling, general and administrative expenses
      have
      been primarily comprised of professional and related fees associated with the
      Company registering to become publicly-traded and maintaining its reporting
      obligations under the Exchange Act. For this period, such expenses amounted
      to
      $42,376. Interest expense is comprised of expenses associated with our notes
      payable to stockholders and amounted to $1,257 since inception.




4




*Off-Balance
      Sheet Arrangements*





We
      are
      not currently a party to, or otherwise involved with, any off-balance sheet
      arrangements that have or are reasonably likely to have a current or future
      material effect on our financial condition, changes in financial condition,
      revenues or expenses, results of operations, liquidity, capital expenditures
      or
      capital resources.





**Subsequent
      Events;**





In
      November 2007, the Company completed an offering of its securities and secured
      $300,000 in equity financing. The Company offered its shares of common stock
      at
      a price of $.06 per share and is obligated to issue to subscribers a total
      of
      5,000,000 shares of its common stock.





**Item
      3. Controls and Procedures.**





Evaluation
      of Disclosure Controls and Procedures.





We
      maintain disclosure controls and procedures that are designed to ensure that
      information required to be disclosed in our reports filed pursuant to the
      Exchange Act, is recorded, processed, summarized and reported within the time
      periods specified in the Securities and Exchange Commission's rules, regulations
      and related forms, and that such information is accumulated and communicated
      to
      our principal executive officer and principal financial officer, as appropriate,
      to allow timely decisions regarding required disclosure.





Within
      the 90 days prior to the filing date of this quarterly report, we carried out
      an
      evaluation, under the supervision and with the participation of our management,
      including our principal executive officer and principal financial officer,
      of
      the effectiveness of the design and operation of our disclosure controls and
      procedures. Based on this evaluation, our principal executive officer and
      principal financial officer concluded that our disclosure controls and
      procedures were effective.





Changes
      in Internal Controls.





There
      have been no significant changes in our internal controls or in other factors
      that could significantly affect these controls and procedures subsequent to
      the
      date we completed our evaluation. Therefore, no corrective actions were
      taken.





5





**PART
      II – OTHER INFORMATION**


**Item
      1. Legal Proceedings.**




None.




**Item
      2. Unregistered Sales of Equity Securities and Use of
      Proceeds.**





There
      were no sales of unregistered securities during the quarter ended September
      30,
      2007





**Item
      3. Defaults Upon Senior Securities.**





None.




**Item
      4. Submission of Matters to a Vote of Security Holders.**





None.




**Item
      5. Other Information.** None.




**Item
      6. Exhibits.** Exhibits
      required by Item 601 of Regulation S-B.





Exhibit
                No.
            
            Description*3.1
            
            Certificate
                of Incorporation, as filed with the Delaware Secretary of State on
                November 20, 2006.*3.2
            
            By-Laws.31.1
            
            Certification
                of the Company's Principal Executive Officer pursuant to Section
                302 of
                the Sarbanes-Oxley Act of 2002, with respect to the registrant's
                Quarterly
                Report on Form 10-QSB for the quarter ended September 30,
                2007.31.2
            
            Certification
                of the Company's Principal Financial Officer pursuant to Section
                302 of
                the Sarbanes-Oxley Act of 2002, with respect to the registrant's
                Quarterly
                Report on Form 10-QSB for the quarter ended September 30,
                2007.32.1
            
            Certification
                of the Company's Principal Executive Officer pursuant to 18 U.S.C.
                Section
                1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
                of
                2002.32.2
            
            Certification
                of the Company's Principal Financial Officer pursuant to 18 U.S.C.
                Section
                1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
                of
                2002.




*
            Filed
                as an exhibit to the Company's Registration Statement on Form 10-SB,
                as
                filed with the Securities and Exchange Commission on May 11, 2007,
                and
                incorporated herein by this
                reference.





6




**SIGNATURES**




Pursuant
      to the requirements of the Securities Exchange Act of 1934, as amended, the
      Registrant has duly caused the Report to be signed on its behalf by the
      undersigned thereunto duly authorized.





SFH
                I ACQUISITION CORP.Dated: November
                14, 2007
            By:
            /s/ Armen
                KarapetyanArmen
                KarapetyanPresident




7